Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Jan 28, 2026
CVX vs. XOM vs. SHEL: Earnings Preview Ahead of Q4 Results

CVX vs. XOM vs. SHEL: Earnings Preview Ahead of Q4 Results

Key Takeaways

  • Chevron (CVX) reports Q4 earnings on January 30, with consensus EPS of $1.53–$1.54 on $52.7 billion in revenue. Results reflect record production from Hess assets and the Permian Basin.

  • ExxonMobil (XOM) also reports on January 30, with expectations of $1.65 EPS on $82.85 billion in revenue, supported by strong output from Guyana and the Permian.

  • Shell (SHEL) reports on February 5, with EPS forecast around $1.26. Q3 adjusted earnings reached $5.4 billion, driven by upstream and LNG strength.

  • All three energy majors face softer oil prices but benefit from production growth; refining margins and 2026 cash flow guidance will be key focus areas.

  • Chevron targets $12.5 billion in incremental free cash flow by 2026 through Hess synergies and cost reductions.

Why This Comparison Matters

Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.

ExxonMobil continues to scale low-cost production in Guyana and the Permian Basin, closely mirroring Chevron’s upstream-driven growth. Shell, by contrast, leans more heavily on LNG and gas, offering diversification amid refining and chemicals margin pressure. Investors are watching volume growth, capital discipline, and medium-term guidance as geopolitical risks, OPEC+ supply decisions, and energy transition investments remain in focus.

Chevron (CVX): Earnings Preview

Chevron is expected to post adjusted Q4 EPS of $1.53–$1.54, down roughly 25% year over year, on revenue of $52.7 billion, slightly higher than last year. Lower Brent crude prices weigh on results, but increased volumes from Hess and operational efficiencies in the Permian provide partial offsets.

In Q3, Chevron delivered an EPS beat of $1.85 on $49.73 billion in revenue, supported by a 21% year-over-year jump in production. Hess contributed approximately 495,000 boe/d, while U.S. output continued to rise. Management’s focus remains on maintaining Permian production near 1 million boe/d, improving downstream margins, and executing on cost-saving initiatives.

Key themes include $3–4 billion in structural cost reductions by 2026, incremental free cash flow of $12.5 billion, and annual capex guidance of $17–17.5 billion. Chevron has beaten earnings estimates in three of the past four quarters, with modest positive stock reactions typically tied to production surprises.

ExxonMobil (XOM): Earnings Preview

ExxonMobil reports Q4 results alongside Chevron on January 30. Consensus expectations call for $1.65 EPS on $82.85 billion in revenue, reflecting slightly lower sales but stable profitability year over year.

The company’s Q3 results exceeded expectations with $1.88 EPS on $85.29 billion in revenue, driven by record production in Guyana (700,000 barrels per day) and Permian output of 1.7 MMboe/d. Refining margins remained supportive, though chemicals continued to lag.

Exxon generated $14.8 billion in operating cash flow and returned $9.4 billion to shareholders in Q3. Its long-term strategy centers on $27–29 billion in annual capex through 2026, targeting $25 billion in earnings growth versus 2024 at $65 Brent crude. Strong balance sheet metrics and a deep inventory of low-cost projects position Exxon favorably versus peers.

Shell (SHEL): Earnings Preview

Shell reports Q4 earnings on February 5, with EPS expected near $1.26. Trading updates suggest the Chemicals & Products segment may approach break-even, while marketing results could be pressured by seasonal tax effects.

In Q3, Shell delivered $5.4 billion in adjusted earnings on $68.15 billion in revenue and generated $12.2 billion in operating cash flow. Upstream production reached records in Brazil and the Gulf of Mexico, while LNG volumes rose 8% quarter over quarter.

Recent asset sales, including the Colonial Pipeline stake, generated roughly $1 billion, supporting a $3.5 billion share buyback. Shell’s gas-heavy portfolio helps cushion oil price weakness, though refining and chemicals remain sensitive to margin volatility. Management continues to emphasize capital discipline, with 2025 capex guidance of $20–22 billion.

Head-to-Head Comparison

  • Production growth: Chevron leads on percentage growth, while Exxon dominates on absolute scale. Shell offers diversification through LNG.

  • Earnings quality: All three beat Q3 estimates, but Q4 EPS expectations reflect softer oil prices. Low breakeven costs in the Permian benefit CVX and XOM, while Shell’s downstream exposure adds risk.

  • Balance sheet and cash flow: Exxon holds an edge with strong debt metrics and consistent shareholder returns.

  • Key risks: Chevron faces integration and geopolitical exposure, Exxon remains exposed to chemicals, and Shell is sensitive to refining margins and energy transition spending.

AI-Based Trading Perspective

Tickeron offers AI-driven trading tools for all three stocks. Chevron and Exxon are supported by short-term corridor-based strategies designed for range-bound markets, while Shell aligns with a trend-following large-cap strategy. These systems are designed to manage volatility around earnings events and improve risk-adjusted entries.

View CVX bot. XOM's counterpart uses identical corridor logic for short-term trades. View XOM bot. SHEL aligns with the Trend Trader for Beginners (60min TA), capturing large-cap trends.View SHEL strategy.

Bottom Line

From a comparative standpoint, ExxonMobil stands out for scale, balance sheet strength, and consistent execution, particularly at moderate oil prices. Chevron offers upside tied to Hess synergies and production growth, while Shell may appeal to investors bullish on LNG and gas markets. As always, outcomes hinge on commodity prices, margins, and forward guidance rather than headline earnings alone.

Disclaimers and Limitations

Related Ticker: CVX, SHEL, XOM

Contributor

Dem Sem's AvatarDem Sem|Expert

Momentum Indicator for CVX turns positive, indicating new upward trend

CVX saw its Momentum Indicator move above the 0 level on August 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CVX just turned positive on August 11, 2026. Looking at past instances where CVX's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for CVX crossed bullishly above the 50-day moving average on July 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVX advanced for three days, in of 381 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 360 cases where CVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.120) is normal, around the industry mean (1.932). P/E Ratio (19.756) is within average values for comparable stocks, (16.808). Projected Growth (PEG Ratio) (0.793) is also within normal values, averaging (1.314). Dividend Yield (0.034) settles around the average of (0.037) among similar stocks. P/S Ratio (1.945) is also within normal values, averaging (3.587).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 123.86B. The market cap for tickers in the group ranges from 39.76K to 678.92B. XOM holds the highest valuation in this group at 678.92B. The lowest valued company is PGAS at 39.76K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was 2%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 20%. PBR experienced the highest price growth at 7%, while SLNG experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was 10%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -30%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 53
Price Growth Rating: 43
SMR Rating: 64
Profit Risk Rating: 27
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
CVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which explores and refines oil and natural gas

Industry IntegratedOil

Profile
Details
Industry
Integrated Oil
Address
6001 Bollinger Canyon Road
Phone
+1 925 842-1000
Employees
45600
Web
https://www.chevron.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.